These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3301883)

  • 1. Risk factor analysis of screening data.
    Begg CB
    J Chronic Dis; 1987; 40(10):989-94. PubMed ID: 3301883
    [No Abstract]   [Full Text] [Related]  

  • 2. Statistical power in breast cancer screening trials and mortality reduction among women 40-49 years of age with particular emphasis on the National Breast Screening Study of Canada.
    Kopans DB; Halpern E; Hulka CA
    Cancer; 1994 Aug; 74(4):1196-203. PubMed ID: 8055437
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening mammography for younger women: back to basics.
    Sox H
    Ann Intern Med; 2002 Sep; 137(5 Part 1):361-2. PubMed ID: 12204022
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of screening mammography for women in their forties.
    Shapiro S
    J Natl Cancer Inst; 1994 Nov; 86(22):1722; author reply 1722-5. PubMed ID: 7966402
    [No Abstract]   [Full Text] [Related]  

  • 5. The mammography dilemma: a crisis for evidence-based medicine?
    Goodman SN
    Ann Intern Med; 2002 Sep; 137(5 Part 1):363-5. PubMed ID: 12204023
    [No Abstract]   [Full Text] [Related]  

  • 6. Recruitment of women into trials.
    Thornton H; Dixon-Woods M
    Lancet; 2002 Jan; 359(9301):164-5. PubMed ID: 11809284
    [No Abstract]   [Full Text] [Related]  

  • 7. Control of breast cancer. The why and how of mass screening.
    Strax P
    Adm Radiol; 1989 Sep; 8(9):30-6. PubMed ID: 10294843
    [No Abstract]   [Full Text] [Related]  

  • 8. [Schematization and forcing of the analysis of mammographic screening effectiveness].
    Liberati A
    Epidemiol Prev; 2002; 26(2):53-4. PubMed ID: 12125384
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
    Whittemore AS
    J Natl Cancer Inst; 2005 Mar; 97(5):400; author reply 400-1. PubMed ID: 15741577
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening mammography and risk of breast cancer.
    Hall FM
    JAMA; 1996 Nov; 276(18):1470; author reply 1470-1. PubMed ID: 8903255
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer screening.
    Witcombe JB
    Clin Radiol; 1991 Oct; 44(4):287. PubMed ID: 1959313
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Efficacy of breast cancer screening in the community according to risk level.
    Duffy SW; Smith RA; Tabar L
    J Natl Cancer Inst; 2005 Nov; 97(22):1703; author reply 1703-4. PubMed ID: 16288125
    [No Abstract]   [Full Text] [Related]  

  • 13. Deficiencies in the analysis of breast cancer screening data.
    Sickles EA; Kopans DB
    J Natl Cancer Inst; 1993 Oct; 85(20):1621-4. PubMed ID: 8179650
    [No Abstract]   [Full Text] [Related]  

  • 14. The National Study of Breast Cancer Screening Protocol for a Canadian Randomized Controlled trial of screening for breast cancer in women.
    Miller AB; Howe GR; Wall C
    Clin Invest Med; 1981; 4(3-4):227-58. PubMed ID: 6802546
    [No Abstract]   [Full Text] [Related]  

  • 15. The breast cancer screening controversy continues.
    Logan-Young WW; Hoffman NY; Janus J
    Ann Intern Med; 1993 May; 118(9):746-7; author reply 748-9. PubMed ID: 8460865
    [No Abstract]   [Full Text] [Related]  

  • 16. Do screening-detected invasive breast cancers have a natural history of their own?
    Holmberg L; Ekbom A; Zack M
    Eur J Cancer; 1992; 28A(4-5):920-3. PubMed ID: 1524924
    [No Abstract]   [Full Text] [Related]  

  • 17. The controversy over screening mammography.
    Gifford DS
    Med Health R I; 2002 Mar; 85(3):101-2. PubMed ID: 11917742
    [No Abstract]   [Full Text] [Related]  

  • 18. The breast cancer screening controversy continues.
    Kopans DB
    Ann Intern Med; 1993 May; 118(9):746; author reply 748-9. PubMed ID: 8460864
    [No Abstract]   [Full Text] [Related]  

  • 19. Population breast-cancer screening.
    Alexander FE; Anderson TJ
    Lancet; 1995 Apr; 345(8953):854; author reply 854-5. PubMed ID: 7898238
    [No Abstract]   [Full Text] [Related]  

  • 20. Limitations of telediaphanography for breast cancer screening.
    Langlands AO
    Br J Hosp Med; 1987 Sep; 38(3):266. PubMed ID: 3315077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.